Industry reports
Editor highlights

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Drug and Medication Analysis & Statistics, April 2014

You might be interested in: drug, vaccine, insulin, more »

» Purchase Premium Reports

1-50 of about 8 400 reports
Oncology Drug Pathway Analyzer (Premium Version)

Oncology Drug Pathway Analyzer (Premium Version)

  • $ 14 850
  • Industry report
  • March 2014
  • by Bioseeker

EXTRA: Free online updates for a year Get instant, interactive pathway modeling on more than 3,400 cancer drugs across more than 100 different cancer types. Drug targets and their pathways are the critical ...

  • Industries : Drug and Medication
  • Countries : United States
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute o ...

  • Industries : Drug and Medication
  • Countries : World
PharmaPoint: Crohn's Disease - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn's Disease - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Crohn's Disease - Global Drug Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon, such as ...

  • Industries : Drug and Medication
  • Countries : World
Oncology Drug Pathway Analyzer (Standard Version)

Oncology Drug Pathway Analyzer (Standard Version)

  • $ 10 350
  • Industry report
  • March 2014
  • by Bioseeker

EXTRA: Free online updates for a year Get instant, interactive pathway modeling on more than 3,400 cancer drugs across more than 100 different cancer types. Drug targets and their pathways are the critical ...

  • Industries : Drug and Medication
  • Countries : United States
Detailed I/E report of Carbendazim export analysis

Detailed I/E report of Carbendazim export analysis

  • $ 7 448
  • Industry report
  • April 2014
  • by CCM International Limited

To provide in-depth import /export analysis of Carbendazim export analysis imported into or exported from China based on the China customs data. To help clients identify the import/export situation with ...

  • Industries : Drug and Medication
  • Countries : China
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - 5EU Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic ...

  • Industries : Drug and Medication
  • Countries : Spain, Italy, France, Germany, United Kingdom, Europe, World
Antibody Drug Conjugates: Technologies and Global Markets

Antibody Drug Conjugates: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • February 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for ADC drugs reached $179 million in 2012 and $396 million in 2013. The market should reach $2.8 billion in 2018 with a compound annual growth rate (CAGR) of 48.1%. ...

  • Industries : Drug and Medication
  • Countries : World
OpportunityAnalyzer: Autism Spectrum Disorder - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Autism Spectrum Disorder - Opportunity Analysis and Forecasts to 2018

  • $ 5 995
  • Industry report
  • March 2014
  • by Global Data

OpportunityAnalyzer: Autism Spectrum Disorder - Opportunity Analysis and Forecasts to 2018 Summary Autism Spectrum Disorders (ASD) is a chronically underserved market currently dominated by the two approved ...

  • Industries : Drug and Medication
PharmaPoint: Crohn's Disease - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn's Disease - 5EU Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Crohn's Disease - 5EU Drug Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds ...

  • Industries : Drug and Medication
PharmaPoint: Crohn's Disease - Canada Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn's Disease - Canada Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Crohn's Disease - Canada Drug Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds ...

  • Industries : Drug and Medication
  • Countries : Canada
PharmaPoint: Crohn's Disease - China Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn's Disease - China Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Crohn's Disease - China Drug Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds ...

  • Industries : Drug and Medication
  • Countries : China
PharmaPoint: Crohn's Disease - US Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn's Disease - US Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Crohn's Disease - US Drug Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds ...

  • Industries : Drug and Medication
  • Countries : United States
PharmaPoint: Crohn's Disease - Japan Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn's Disease - Japan Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Crohn's Disease - Japan Drug Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds ...

  • Industries : Drug and Medication
  • Countries : Japan
PharmaPoint: Crohn's Disease - India Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn's Disease - India Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Crohn's Disease - India Drug Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds ...

  • Industries : Drug and Medication
  • Countries : India
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Japan Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Japan Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Japan Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute o ...

  • Industries : Drug and Medication
  • Countries : Japan
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Canada Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Canada Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Canada Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute o ...

  • Industries : Drug and Medication
  • Countries : Canada
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - US Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - US Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - US Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic ...

  • Industries : Drug and Medication
  • Countries : United States
Global Veterinary Vaccines Industry

Global Veterinary Vaccines Industry

  • $ 4 950
  • Industry report
  • February 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million by the following Product Segments: Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines ...

  • Industries : Drug and Medication
  • Countries : World
Human Reproductive Technologies Market (Infertility: Drugs and Procedures & Contraceptives: Drugs and Devices) - Global Industry Analysis, Size, Procedures, Share, Growth, Trends and Forecast, 2013 - 2019

Human Reproductive Technologies Market (Infertility: Drugs and Procedures & Contraceptives: Drugs and Devices) - Global Industry Analysis, Size, Procedures, Share, Growth, Trends and Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • April 2014
  • by Transparency Market Research

This report covers the market analysis for various drugs, devices and treatment technologies used in assistance and to control human reproduction. The stakeholders for this study include manufacturers ...

  • Industries : Drug and Medication
  • Countries : World
Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • March 2014
  • by Transparency Market Research

Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban (bupropion), ...

  • Industries : Drug and Medication
  • Countries : World
Antibacterial Drugs Market (By Class and Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Antibacterial Drugs Market (By Class and Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • March 2014
  • by Transparency Market Research

Antibacterial Drugs Market (By Class - Aminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Quinolones/ Fluoroquinolones, Macrolides and Phenicols, and Pipeline Analysis) - Global Industry Analysis, ...

  • Industries : Drug and Medication
  • Countries : World
Ophthalmic Drugs Market (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018

Ophthalmic Drugs Market (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018

  • $ 4 795
  • Industry report
  • January 2014
  • by Transparency Market Research

The global ophthalmic drugs market is rapidly growing due to increasing prevalence of eye disorders such as glaucoma, dry eye diseases and retinal diseases. Changing lifestyle, improved medical infrastructure, ...

  • Industries : Drug and Medication
  • Countries : World
Diabetes : Herbal molecules vs. Pharmaceutical drugs - Volume 1 : Cinnamon global markets, competitors and opportunities - 2014-2019 Analysis and forecasts

Diabetes : Herbal molecules vs. Pharmaceutical drugs - Volume 1 : Cinnamon global markets, competitors and opportunities - 2014-2019 Analysis and forecasts

  • $ 3 900
  • Industry report
  • March 2014
  • by Amadee+Company

Abstract Diabetes is a metabolic disorder arising mainly due to the fault in the production of insulin or mounting resistance to its action. In the case of Diabetes, the most serious problem is the side ...

  • Industries : Drug and Medication
  • Countries : World
Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases

Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases

  • $ 3 900
  • Industry report
  • February 2014
  • by CBR Pharma Insights

More than 50% of prescriptions is written for people aged 65 years and older. Many older people suffer from comorbid conditions and one in three takes at least five drugs or more on a daily basis. This ...

  • Industries : Drug and Medication
Vaccine Development Strategies - Refocusing Efforts to Address New Challenges

Vaccine Development Strategies - Refocusing Efforts to Address New Challenges

  • $ 3 900
  • Industry report
  • February 2014
  • by CBR Pharma Insights

Vaccines are one of the most important healthcare advances and have saved millions of lives through immunizing against some of the most deadly diseases. With protection against a number of key viral and ...

  • Industries : Drug and Medication
Analytical Tool - Cancer Vaccines

Analytical Tool - Cancer Vaccines

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool - Cancer Vaccines" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer vaccine drug development. It is at the same time a map of the ...

  • Industries : Drug and Medication
Engerix-B (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Engerix-B (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Engerix-B (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation ...

  • Industries : Drug and Medication
  • Countries : Canada, Germany, Spain, Italy, France, World, Europe, United States, United Kingdom, Japan
Ambirix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Ambirix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Ambirix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation ...

  • Industries : Drug and Medication
  • Countries : World, United Kingdom, Canada, Spain, Italy, France, Germany, Japan
Bimmugen (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Bimmugen (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Bimmugen (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation ...

  • Industries : Drug and Medication
  • Countries : Japan
Comvax (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Comvax (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Comvax (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation ...

  • Industries : Drug and Medication
  • Countries : United States, World

» Read our Company Profiles

85 Companies

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.